Shea E. Hogan

Featured in: Favicon

ahajournals.org Favicon

jwatch.org Favicon

annalsofvascularsurgery.com

Articles

Do Older STEMI Patients with Cardiogenic Shock Benefit from Microaxial Flow Pump Use?

Jan 23, 2025 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing An exploratory analysis of randomized data demonstrates higher mortality and less clear benefit of mAFP use in older patients with STEMI-related cardiogenic shock. The DanGer Shock trial established that microaxial flow pump (mAFP) use decreases all-cause mortality in certain patients presenting with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock (CS; NEJM JW Cardiol Apr 8 2024 and N Engl J Med 2024; 390:1382).
Are We Moving Toward Parity?

Dec 20, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing In a contemporary setting, women continued to have worse outcomes than men after CABG. Historically, women undergoing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have had worse outcomes than men undergoing these procedures. With the advent of new medical therapies and procedural techniques, this gap may be narrowing.
An Early Look at a Novel Intranasal Loop Diuretic

Dec 4, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing In a phase 1 study, a bumetanide nasal spray was safe and had similar pharmacokinetics compared with oral bumetanide. A common cause of decompensated heart failure is decreased oral diuretic absorption due to gut edema, often requiring inpatient admission for intravenous diuretics.
What's the Best Approach?

Nov 16, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing Randomized trial results favor catheter ablation over antiarrhythmic drugs as first-line therapy for recurrent VT. Patients with recurrent ventricular tachycardia (VT) from myocardial scar after a myocardial infarction (MI) have worse quality of life and outcomes than those without recurrent VT.
A Race to the Bottom?

Nov 6, 2024 | jwatch.org | Shea E. Hogan
Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients

Oct 23, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing Any atherosclerotic plaque is bad, and its presence portends a worse prognosis if modifiable risk factors like hypertension and smoking are not addressed. Noninvasive quantitative imaging of subclinical atherosclerosis has improved cardiovascular risk predictions. The current researchers used data from the U.S. BioImage study to evaluate how atherosclerotic burden and progression affect all-cause mortality in asymptomatic patients.
Is Intracranial Atherosclerotic Disease Associated with Dementia Risk?

Oct 9, 2024 | jwatch.org | Shea E. Hogan
Is Fasting Before Catheterization Procedures Really Safer?

Sep 26, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing A no-fasting approach prior to elective cath lab procedures resulted in fewer safety events and improved patient satisfaction. Most cath labs in the U.S. follow the 2017 American Society of Anesthesiologists guideline for fasting before elective procedures (6 hours for solid food and 2 hours for clear liquid) despite a lack of strong data to support this practice.
To Stop or Not to Stop Aspirin Before Intermediate Risk Noncardiac Surgery

Sep 19, 2024 | jwatch.org | Shea E. Hogan

Shea E. Hogan, MD, MSCS, FACC, FSCAI, FSVM, reviewing In a randomized trial, continued aspirin in the perioperative period did not affect ischemic and major bleeding endpoints, although these patients had more minor bleeding events. The effect of perioperative aspirin monotherapy on ischemic and bleeding events in patients with coronary drug-eluting stents (DES) is not known.
Are We Nearing the End of 12-Month DAPT Following PCI?

Sep 11, 2024 | jwatch.org | Shea E. Hogan